Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$2.75M Buy
21,070
+2,401
+13% +$318K 0.05% 168
2017
Q1
$2.48M Sell
18,669
-169
-0.9% -$20.8K 0.04% 185
2016
Q4
$2.11M Sell
18,838
-1,108
-6% -$116K 0.04% 200
2016
Q3
$2.19M Sell
19,946
-1,236
-6% -$131K 0.04% 185
2016
Q2
$2.1M Buy
21,182
+124
+0.6% +$12.1K 0.04% 192
2016
Q1
$2.11M Sell
21,058
-4,554
-18% -$411K 0.04% 181
2015
Q4
$2.27M Sell
25,612
-9,319
-27% -$849K 0.04% 185
2015
Q3
$3.07M Sell
34,931
-9,589
-22% -$908K 0.06% 151
2015
Q2
$4.64M Buy
44,520
+2,502
+6% +$267K 0.08% 137
2015
Q1
$4.25M Sell
42,018
-1,804
-4% -$190K 0.08% 141
2014
Q4
$4.72M Sell
43,822
-4,729
-10% -$480K 0.09% 126
2014
Q3
$4.8M Buy
48,551
+18,377
+61% +$1.73M 0.09% 127
2014
Q2
$2.81M Buy
30,174
+488
+2% +$42.1K 0.05% 178
2014
Q1
$2.77M Buy
+29,686
New +$2.64M 0.05% 175

Other funds holding ASML

Geneva Advisors's ASML Position: Q2 2017 in Review

Geneva Advisors increased its ASML (ASML) stake by 13% in Q2 2017, buying an estimated $318K and bringing the position to 21,070 shares worth $2.75M. The position accounts for 0.05% of the portfolio, ranked #168.

Geneva Advisors first reported a position in ASML in Q1 2014 and has held it in 14 quarters since. The position peaked at $4.8M in Q3 2014. 230 funds tracked by Wall St. Rank hold ASML as of Q2 2017.

  • Geneva Advisors held 21,070 shares of ASML worth $2.75M as of Q2 2017.
  • Geneva Advisors bought 2,401 ASML shares in Q2 2017, an estimated $318K.
  • ASML made up 0.05% of Geneva Advisors's portfolio in Q2 2017, its #168 holding.
  • Geneva Advisors first reported a position in ASML in Q1 2014 and has held it in 14 quarters since.
  • Geneva Advisors's ASML position peaked at $4.8M in Q3 2014.
  • 230 funds tracked by Wall St. Rank held ASML as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.